Tomoaki Kato
Columbia University
286 Papers
1.7K Citations
Tomoaki Kato is an academic researcher from Columbia University. The author has contributed to research in topics: Transplantation & Medicine. The author has an hindex of 49, co-authored 269 publications. Previous affiliations of Tomoaki Kato include Columbia University Medical Center & Boston Children's Hospital.
Chat about Author
Papers
Inclusion of spleen in pediatric multivisceral transplantation.
Tomoaki Kato,Gary Kleiner,André Ibrahim David,G. Selvaggi,Seigo Nishida,Juan Madariaga,John W. Thompson,Philip Ruiz,Andreas G. Tzakis +8 more
- 01 Jul 2006
TL;DR: Rejection-free survival may be prolonged, but the risk of GVHD may be increased, and recipients of the spleen as part of a multivisceral graft had significantly lower platelet counts.
9
Etiology and Management of Alimentary Tract Ulcers in Pediatric Intestinal Transplantation Patients
G. Selvaggi,S. Sarkar,Naveen K Mittal,B. C. Acar,Deborah Weppler,Tomoaki Kato,Panagiotis Tryphonopoulos,Andreas G. Tzakis,Philip Ruiz +8 more
- 01 Jul 2006
TL;DR: It is demonstrated that PTLD and acute rejection are the most common causes of chronic ulcer formation and that biopsy samples should be collected simultaneously from both the ulcer edge and intervening mucosa since pathological changes can vary depending on the underlying cause(s).
9
Treatment for local control of retroperitoneal and pelvis sarcomas: A review of the literature.
TL;DR: A review of the current management of retroperitoneal and pelvis sarcomas, focusing on studies of surgery and radiation therapy to maximize local control, is presented in this paper .
9
Transplantation for the treatment of intra abdominal fibromatosis.
Andreas G. Tzakis,Panagiotis Tryphonopoulos,Seigo Nishida,Juan Madariaga,Tomoaki Kato,Naveen K Mittal,D. M. Levi,Jang Moon,G. Selvaggi,Nikolaos Pyrsopoulos,P. Cantwell,Phillip Ruiz +11 more
TL;DR: Intestinal allo-, or autotransplantation combined with transplantation of the abdominal wall can be lifesaving for patients suffering from extensive intra-abdominal fibromatosis.
9
Living-donor liver transplantation: current perspective.
TL;DR: Ongoing research in immunosuppression minimization, withdrawal and tolerance induction may make living donation a desired first-line operation rather than a necessary albeit less-desirable option.
9